Product review
Panacea shilajit tablets review
A $75 Altai-sourced shilajit in tablet form, with published test documents that are unusually hard to read. What the documentation shows and what it omits.
Affiliate disclosure.We earn a commission if you buy through links on this page, at no extra cost to you. It does not change what we recommend, and we say so when we think you should not buy.
What it is
Shilajit in tablet form, 240 tablets at $75, with the material stated as sourced from the Altai Mountains and each tablet stated to contain 200 mg. At the manufacturer’s suggested two-tablet serving, one bottle is a 120-day supply.
That last figure is worth pausing on, because it changes how the price reads. Seventy-five dollars is a lot for a supplement bottle and not very much for four months of one. Whether that is good value depends entirely on the material, which brings us to the documentation.
Format: tablets rather than resin
Most shilajit is sold as a resin — a tar-like material you dose with a spoon. Tablets are the less common choice and the trade-off is real in both directions.
Tablets are consistent, portable, and dosed without guesswork, which is not nothing when the alternative is estimating a rice-grain-sized portion of something with the consistency of roofing material. Resin is closer to the raw material and lets you see and smell what you bought, which some buyers reasonably value as its own kind of verification.
Neither format is inherently purer. Purity is a property of the source material and the processing, not the shape it arrives in.
Sourcing
The Altai Mountains are among the more credible stated origins in this category. The relevant point is not romance about mountains — it is that collection region correlates with contamination risk, and a specific named region is a more accountable claim than “the Himalayas,” which functions as a marketing region rather than a geographic one.
We note this as the manufacturer’s stated sourcing. We have not verified the supply chain, and we do not have a mechanism to.
The documentation, and its one significant problem
This manufacturer does publish test documentation — a certificate of analysis and a contaminant test document — which already places it ahead of most of the category. Genuinely to its credit, it also maintains published test pages across most of its product line.
Here is the problem. Those documents are published as PDFs linked from a page built almost entirely out of images. There is no readable text, nothing is tabulated, nothing is comparable across products, and nothing about the presentation invites you to actually open them. In our view a test result nobody reads does not function as evidence for the buyer — it functions as a signal that evidence exists somewhere, which is a much weaker thing.
This matters more than it sounds. The whole argument for paying a premium in this category is documented purity. Publishing that documentation in a form that is effectively unreadable gives away most of the advantage of having done the testing.
What the certificate actually contains
Having now read it properly, credit where it is due: it names two laboratories with accreditation numbers, gives a batch number and production date, and — unusually for this category — reports measured values with measurement uncertainty rather than pass-or-fail verdicts. That is better practice than most consumer-facing supplement documentation, and it is what makes the rest of this paragraph possible.
What it does not contain: cadmium and mercury are not among the reported analytes. Arsenic and lead are. So on two of the four metals people usually look for, the document is silent — not reassuring, not damning, simply unanswered. No analytical methods are stated and no detection limits are given.
The accompanying microbiology document is published as a scanned image with no text layer, so it cannot be read, searched or checked by any automated means — and the submission date in its filename predates the production date on the chemistry certificate, which suggests the two describe different lots.
We have worked the reported lead figure through to a daily dose and compared it against the two reference points in common use, in the certificate guide. The short version is that the same number passes one and exceeds the other, which is exactly why a measured value is worth more than a verdict.
What we would want to see
- Cadmium and mercury added to the reported analytes.
- Detection limits and analytical methods stated.
- Measured values presented as readable text, not scanned images.
- A clear batch or lot linkage between the published certificate and shipping stock.
- The full analyte list stated on the page rather than buried.
- A date on the page itself, so a reader can judge currency without opening a file.
None of these are difficult. All of them would make the existing testing far more persuasive than it currently is.
Verdict
Better documented than most of the category, sold in a format that trades a little authenticity for a lot of convenience, at a price that looks high per bottle and reasonable per day.
The reason to consider it is that the testing exists. The reason to be a little frustrated by it is that the testing is presented as though nobody expected you to look.
If you are buying shilajit at all, buy from someone who publishes documents — and then actually open them. If you are not sure you want shilajit in the first place, the purity guide is the more useful page, and it may talk you out of the purchase entirely. That is a legitimate outcome.
Constraints — what you are actually signing up for
What we could not determine
Where each claim on this page comes from
Every factual statement above is listed here with its source. Rows marked “manufacturer claim” are the manufacturer’s description of its own product, reported without endorsement.
| Tier | Claim | Kind | Source |
|---|---|---|---|
| D | MitoLife publishes a certificate of analysis and a contaminant test document for this product. | Published lab result | MitoLife Panacea lab page, linked certificate documents |
| D | The published certificate reports arsenic and lead as measured values with uncertainty, and does not report cadmium or mercury. | Published lab result | MitoLife Panacea certificate of analysis, batch 04 |
| B | The bottle contains 240 tablets, which at the stated two-tablet serving is a 120-day supply. | Specification | MitoLife Panacea product page, count and suggested usage |
| A | MitoLife states each tablet contains 200 mg of shilajit and that the material is sourced from the Altai Mountains. | Manufacturer statement | MitoLife Panacea product page per MitoLife's product page |
| F | Publishing test documents as linked PDFs on an image-based page means very few buyers ever read them. | Our editorial view | Editorial review of the MitoLife lab page presentation Our view: a test result nobody reads does not function as evidence for the buyer. |
| F | The accompanying microbiology document is published as a scanned image with no text layer, and the submission date encoded in its filename precedes the production date on the chemistry certificate. | Our editorial view | Our attempt to read both published documents Our view: a document that cannot be read, indexed or checked does not function as published evidence. |